Study #2023-0615
A prospective cohort study of cytomegalovirus (CMV) viral load kinetics as a predictor of outcome in patients with severe sepsis or septic shock in the setting of chemotherapy-induced neutropenia.
MD Anderson Study Status
Enrolling
Treatment Agent
Description
CMV viral load kinetics as a predictor of outcome in patients with severe sepsis
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Unknown Sites
Study phase:
Not applicable
Physician name:
Fareed Khawaja
Department:
Infectious Diseases
For general questions about clinical trials:
1-877-839-0558
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.